These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9053451

  • 1. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.
    Bodian DL, Davis SJ, Morgan BP, Rushmere NK.
    J Exp Med; 1997 Feb 03; 185(3):507-16. PubMed ID: 9053451
    [Abstract] [Full Text] [Related]

  • 2. Mapping the active site of CD59.
    Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S.
    J Exp Med; 1997 Feb 17; 185(4):745-53. PubMed ID: 9034152
    [Abstract] [Full Text] [Related]

  • 3. Elimination of potential sites of glycosylation fails to abrogate complement regulatory function of cell surface CD59.
    Rother RP, Zhao J, Zhou Q, Sims PJ.
    J Biol Chem; 1996 Sep 27; 271(39):23842-5. PubMed ID: 8798614
    [Abstract] [Full Text] [Related]

  • 4. Defining the CD59-C9 binding interaction.
    Huang Y, Qiao F, Abagyan R, Hazard S, Tomlinson S.
    J Biol Chem; 2006 Sep 15; 281(37):27398-404. PubMed ID: 16844690
    [Abstract] [Full Text] [Related]

  • 5. Insights into the human CD59 complement binding interface toward engineering new therapeutics.
    Huang Y, Smith CA, Song H, Morgan BP, Abagyan R, Tomlinson S.
    J Biol Chem; 2005 Oct 07; 280(40):34073-9. PubMed ID: 16079145
    [Abstract] [Full Text] [Related]

  • 6. Identification of mutations in rat CD59 that increase the complement regulatory activity.
    Hinchliffe SJ, Morgan BP.
    Biochemistry; 2000 May 16; 39(19):5831-7. PubMed ID: 10801333
    [Abstract] [Full Text] [Related]

  • 7. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
    Lockert DH, Kaufman KM, Chang CP, Hüsler T, Sodetz JM, Sims PJ.
    J Biol Chem; 1995 Aug 25; 270(34):19723-8. PubMed ID: 7544344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.
    Ninomiya H, Stewart BH, Rollins SA, Zhao J, Bothwell AL, Sims PJ.
    J Biol Chem; 1992 Apr 25; 267(12):8404-10. PubMed ID: 1373727
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis.
    Zhu X, Gao M, Ren S, Wang Q, Lin C.
    Cell Mol Immunol; 2008 Apr 25; 5(2):141-6. PubMed ID: 18445344
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.